Verdad Advisers »

Design Therapeutics shares owned by Verdad Advisers

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Verdad Advisers from 13F filings

Historical chart of Verdad Advisers investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by Verdad Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by Verdad Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $982k 92k 10.64

More positions owned by Verdad Advisers

Belite Bio Sponsored Ads (BLTE)
State Street Corporation (STT)
Autohome Sp Ads Rp Cl A (ATHM)
Revolution Medicines (RVMD)
Zymeworks Del (ZYME)
Cal Maine Foods Com New (CALM)
Zoom Communications Cl A (ZM)
California Res Corp Com Stock (CRC)
Tenax Therapeutics Com New (TENX)
ACADIA Pharmaceuticals (ACAD)
Par Pac Holdings Com New (PARR)
Johnson & Johnson (JNJ)
Micron Technology (MU)
Nurix Therapeutics (NRIX)
Comcast Corp Cl A (CMCSA)

View all positions for Verdad Advisers

Top funds holding Design Therapeutics

Sr One Capital Management
RA Capital Management
Point72 Asset Management
Baker Bros. Advisors
BlackRock
Logos Global Management
Driehaus Capital Management
Vivo Capital
Almitas Capital
Vanguard Capital Management
Woodline Partners
Trails Edge Capital Partners
FMR
Kynam Capital Management
Geode Capital Management

View all funds holding Design Therapeutics